Halozyme Therapeutics, Inc.
$111.96
$0.50(-0.44%)
HALO
Halozyme Therapeutics, Inc.
$111.96
1D:
-0.4%
1Y:
43.5%
US40637H1095Healthcare
Chart
Key stats
52-Week Range$111.96
$61.23
$112.66
Market capitalization
$13.34BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
31.95Basic EPS (TTM)
$3.52Net income (TTM)
$413.60MRevenue (TTM)
$1.66BAvg. volume
2.02MBeta (1Y)
0.88Employees
423Market capitalization
$13.34BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
31.95Basic EPS (TTM)
$3.52Net income (TTM)
$413.60MRevenue (TTM)
$1.66BAvg. volume
2.02MBeta (1Y)
0.88Employees
423Screener Quick Check
Sign in to check this stock against your screeners
Sign InRelated Stocks
$240.74
1D:
-1.3%
1Y:
83.5%
IE00B4Q5ZN47Healthcare
Mkt Cap
$15.12B
P/E Ratio TTM
15.8
Revenue TTM
$4.60B
Beta
0.32
Earnings TTM
$940.76M
Dividend Yield TTM
0.00%
$110.29
1D:
-4.0%
1Y:
38.2%
US2183521028Healthcare
Mkt Cap
$11.92B
P/E Ratio TTM
212.1
Revenue TTM
$830.81M
Beta
0.45
Earnings TTM
$54.90M
Dividend Yield TTM
0.00%